Amplia Therapeutics (INNMF) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Narmafotinib Ascending Doses, Narmafotinib Dose Comparison | Pancreatic Cancer Metastatic | phase1AndPhase2 | Recruiting | A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer | Apr 29, 2025 | ― |
| Amp945 Ascending Doses, Amp945 Rp2d | Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pdac | phase1AndPhase2 | Active Not Recruiting | ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | Apr 07, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Narmafotinib Ascending Doses, Narmafotinib Dose Comparison | phase1AndPhase2 | Pancreatic Cancer Metastatic | Recruiting | A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer | Apr 29, 2025 | ― |
| Amp945 Ascending Doses, Amp945 Rp2d | phase1AndPhase2 | Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pdac | Active Not Recruiting | ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | Apr 07, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Amplia Therapeutics Ltd. (INNMF) have in its pipeline
Amplia Therapeutics INNMF is currently developing the following drugs: Narmafotinib Ascending Doses, Narmafotinib Dose Comparison, Amp945 Ascending Doses, Amp945 Rp2d. These drug candidates are in various stages of clinical development as the company works toward FDA approval.